ConductScience.org, home

Paper71446

Prostaglandins and breast cancer.

Bennett A and 5 others. Lancet, 1977. Cited by 278 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Prostaglandins and breast cancer. Papers, record 71446. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/71446

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prostaglandins and breast cancer.
PubMed
Journal
Lancet
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
278
iCite
Relative citation ratio, by iCite
8.33
iCite
Revised in PubMed
2019-06-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bennett AA
2Charlier EME M
3McDonald AMA M
4Simpson JSJ S
5Stamford IFI F
6Zebro TT

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone NeoplasmsMajor topic
Breast NeoplasmsMajor topic
Neoplasm InvasivenessMajor topic
Prostaglandins EMajor topic
Prostaglandins FMajor topic
Adolescent
Adult
Aged
Aspirin
Female
Humans
In Vitro Techniques
Middle Aged
Neoplasm Metastasis
Neoplasms
Prostaglandin Antagonists

Source PubMed

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 278 citations.

PMIDTitleJournalYearIn PapersSource
34,203,324Toward Multitasking Pharmacological COX-Targeting Agents: Non-Steroidal Anti-Inflammatory Prodrugs with Antiproliferative Effects.Molecules2021https://conductscience.org/library/papers/34203324PubMed
32,545,461Low-Dose Aspirin Use Significantly Improves the Survival of Late-stage NPC: A Propensity Score-Matched Cohort Study in Taiwan.Cancers (Basel)2020https://conductscience.org/library/papers/32545461PubMed
30,999,962Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study.Breast Cancer Res2019https://conductscience.org/library/papers/30999962PubMed
28,597,105Role of Aspirin in Breast Cancer Survival.Curr Oncol Rep2017https://conductscience.org/library/papers/28597105PubMed
28,271,910Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer.Expert Opin Investig Drugs2017https://conductscience.org/library/papers/28271910PubMed
28,160,159Aspirin use is associated with lower mammographic density in a large screening cohort.Breast Cancer Res Treat2017https://conductscience.org/library/papers/28160159PubMed
24,816,739COX2 expression in high-grade breast cancer: evidence for prognostic significance in the subset of triple-negative breast cancer patients.Med Oncol2014https://conductscience.org/library/papers/24816739PubMed
24,789,723Cyclooxygenase-2 polymorphisms and breast cancer associated risk in Pakistani patients.Pathol Oncol Res2015https://conductscience.org/library/papers/24789723PubMed
23,607,319The extrathyronine actions of iodine as antioxidant, apoptotic, and differentiation factor in various tissues.Thyroid2013https://conductscience.org/library/papers/23607319PubMed
23,576,215Nutrient intake and nutrient patterns and risk of lung cancer among heavy smokers: results from the COSMOS screening study with annual low-dose CT.Eur J Epidemiol2013https://conductscience.org/library/papers/23576215PubMed
23,566,419A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer.Breast Cancer Res2013https://conductscience.org/library/papers/23566419PubMed
22,002,714Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.Cancer Metastasis Rev2011https://conductscience.org/library/papers/22002714PubMed
20,396,544Clinical value of cyclooxygenase-2 expression in human breast carcinoma.Cancer Res Treat2004https://conductscience.org/library/papers/20396544PubMed
20,159,825Aspirin intake and survival after breast cancer.J Clin Oncol2010https://conductscience.org/library/papers/20159825PubMed
18,792,778Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function.Breast Cancer Res Treat2009https://conductscience.org/library/papers/18792778PubMed
16,497,869
Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathways.
J Clin Pathol2006https://conductscience.org/library/papers/16497869PubMed
15,123,779Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas.J Leukoc Biol2004https://conductscience.org/library/papers/15123779PubMed
14,587,862COX-2 inhibitors for the prevention of breast cancer.J Mammary Gland Biol Neoplasia2003https://conductscience.org/library/papers/14587862PubMed
14,586,398Tumor suppressor p53 inhibits transcriptional activation of invasion gene thromboxane synthase mediated by the proto-oncogenic factor ets-1.Oncogene2003https://conductscience.org/library/papers/14586398PubMed
12,884,024Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis.J Cancer Res Clin Oncol2003https://conductscience.org/library/papers/12884024PubMed

See all 53 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/71446

GET https://conductscience.org/api/papers/v1/71446/cited_by?page=2